New Zealand - Re-Export of Extracts of Glands for Therapeutic Use
Since 2013, New Zealand Re-Export of Extracts of Glands for Therapeutic Use fell by 22.2% year on year. In 2018, the country was ranked number 5 among other countries in Re-Export of Extracts of Glands for Therapeutic Use with $311.12. New Zealand is overtaken by United Arab Emirates, which was number 4 at $5,186.18 and is followed by Canada with $183.09. United States ranked the highest with $266,511 in 2019, a fall of 17.2% versus 2018. United States recorded the best 5 years average growth at +9.1% per year, while Canada was the worst growing country at -77.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2018 | 311.12 |
| 2017 | |
| 2016 | 5,541.84 |
| 2015 | |
| 2014 |
Download all data from 2003 to 2018
How does New Zealand rank in Re-Export of Extracts of Glands for Therapeutic Use?
| # | 6 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
266,511.00 | 2019 | -17.2 % | +9.1 % | View data | |
| 2 |
#2
Georgia
|
73,777.45 | 2018 | NA | NA | View data | |
| 4 |
#4
United Arab Emirates
|
5,186.18 | 2018 | NA | +3.4 % | View data | |
| 5 |
#5
New Zealand
|
311.12 | 2018 | NA | -22.2 % | View data | |
| 6 |
#6
Canada
|
183.09 | 2019 | -99.9 % | -77.8 % | View data | |